Events

Digital and hybrid events

12th Annual Outsourcing in Clinical Trials: Medical Devices Europe 2024

Munich, Germany

30 - 31 Jan 2024

Event details

16th Annual Outsourcing in Clinical Trials West Coast 2024

Burlingame, USA

6 - 7 Feb 2024

Event details

9th Annual Outsourcing in Clinical Trials & Clinical Trial Supply Israel 2024

Tel-Aviv, Israel

26 - 27 Feb 2024

Event details

25th Annual Clinical Trial Supply Europe 2024

Barcelona, Spain

6 - 7 Mar 2024

Event details

20th Annual Temperature Controlled Logistics in Biopharmaceuticals Europe 2024

Barcelona, Spain

6 - 7 Mar 2024

Event details

13th Annual Clinical Trial Supply New England 2024

Boston, USA

9 - 10 Apr 2024

Event details

13th Annual Outsourcing in Clinical Trials Southeast 2024

Raleigh-Durham, USA

16 - 17 Apr 2024

Event details

11th Annual Clinical Trials in Oncology West Coast 2024

Burlingame, USA

23 - 24 Apr 2024

Event details

14th Annual Outsourcing in Clinical Trials Europe 2024

Barcelona, Spain

7 - 8 May 2024

Event details

15th Annual Outsourcing in Clinical Trials East Coast 2024

King of Prussia, USA

21 - 22 May 2024

Event details

Virtual events

Digital Transformation and Emerging Technologies in the Healthcare Industry

Online

31 Jan 2024

Event details

Other media partner events

Drug Safety Symposium 2024

Dubai, UAE

14 Feb 2024

Event details

PHARMAP

Amsterdam, the Netherlands

22 - 23 Apr 2024

Event details

Go to article: Home | Inside the world of priority review vouchers where time is moneyGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Trends & InsightGo to article: Molnar-Institute Company InsightGo to article: Molnar-InstituteGo to article: Lactalis IngredientsGo to article: In DepthGo to article: Inside the world of priority review vouchers where time is money Go to article: Quality and sustainability: The balancing act for pharma manufacturingGo to article: 2023 in review: Cancer vaccines dose up on advances with tailored approachesGo to article: Diversity and ePROs: Still siloed concepts in the era of DCTs? Go to article: Q&A: Tackling the rise of fake anti-obesity drugs on the market Go to article: Patching the problem of EU drug shortagesGo to article: Out-of-spec cell therapy manufacturing: an ethical dilemma for CDMOs and doctorsGo to article: NiproGo to article: phasetwoGo to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: Foreword: What’s next for the Internet of ThingsGo to article: An introduction to the Internet of Things Go to article: The digital ecosystem of the IoTGo to article: Timeline: Internet of ThingsGo to article: The impact of IoT on the pharma industry Go to article: Applications of IoT in the pharma industryGo to article: Latest news: IoT in pharmaGo to article: Analyst Q&A: IoT in pharmaGo to article: Bupa leverages unique position to develop IoT and AI features Go to article: IoT innovation: Leading companies in microneedles for transdermal drug deliveryGo to article: IoT in the pharmaceutical industry: analysing innovation, investment and hiring trendsGo to article: GlobalData Thematic IntelligenceGo to article: Sponsored SupplementsGo to article: Avenga Company InsightGo to article: ListingsGo to article: EventsGo to article: Innovation RankingsGo to article: Buyer's GuidesGo to article: Next issue